Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry
Aims: We examine the effects of symptoms and cardiovascular disease (CVD) events on health-related quality of life (HRQOL) and healthcare costs in a European population with atrial fibrillation (AF). Methods and results: In the EURObservational Research Programme on AF long-term general registry, AF...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2024
|
| _version_ | 1826313188011933696 |
|---|---|
| author | Walli-Attaei, M Little, M Luengo-Fernandez, R Gray, A Torbica, A Maggioni, AP Bairami, F Huculeci, R Aboyans, V Timmis, AD Vardas, P Leal, J |
| author_facet | Walli-Attaei, M Little, M Luengo-Fernandez, R Gray, A Torbica, A Maggioni, AP Bairami, F Huculeci, R Aboyans, V Timmis, AD Vardas, P Leal, J |
| author_sort | Walli-Attaei, M |
| collection | OXFORD |
| description | Aims: We examine the effects of symptoms and cardiovascular disease (CVD) events on health-related quality of life (HRQOL) and healthcare costs in a European population with atrial fibrillation (AF). Methods and results: In the EURObservational Research Programme on AF long-term general registry, AF patients from 250 centres in 27 European countries were enrolled and followed for 2 years. We used fixed effects models to estimate the association of symptoms and CVD events on HRQOL and annual healthcare costs. We found significant decrements in HRQOL in AF patients in whom ST-segment elevation myocardial infarction (STEMI) [−0.075 (95% confidence interval −0.144, −0.006)], angina or non-ST-elevation myocardial infarction (NSTEMI) [−0.037 (−0.071, −0.003)], new-onset/worsening heart failure [−0.064 (−0.088, −0.039)], bleeding events [−0.031 (−0.059, −0.003)], thromboembolic events [−0.071 (−0.115, −0.027)], mild symptoms [0.037 (−0.048, −0.026)], or severe/disabling symptoms [−0.090 (−0.108, −0.072)] occurred during the follow-up. During follow-up, annual healthcare costs were associated with an increase of €11 718 (€8497, €14 939) in patients with STEMI, €5823 (€4757, €6889) in patients with angina/NSTEMI, €3689 (€3219, €4158) in patients with new-onset or worsening heart failure, €3792 (€3315, €4270) in patients with bleeding events, and €3182 (€2483, €3881) in patients with thromboembolic events, compared with AF patients without these events. Healthcare costs were primarily driven by inpatient costs. There were no significant differences in HRQOL or healthcare resource use between EU regions or by sex. Conclusion: Symptoms and CVD events are associated with a high burden on AF patients and healthcare systems throughout Europe. |
| first_indexed | 2024-09-25T04:09:13Z |
| format | Journal article |
| id | oxford-uuid:9dc62d63-96f7-47ef-b3b2-c0e3900ded0f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:09:13Z |
| publishDate | 2024 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:9dc62d63-96f7-47ef-b3b2-c0e3900ded0f2024-06-11T20:07:11ZHealth-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registryJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9dc62d63-96f7-47ef-b3b2-c0e3900ded0fEnglishJisc Publications RouterOxford University Press2024Walli-Attaei, MLittle, MLuengo-Fernandez, RGray, ATorbica, AMaggioni, APBairami, FHuculeci, RAboyans, VTimmis, ADVardas, PLeal, JAims: We examine the effects of symptoms and cardiovascular disease (CVD) events on health-related quality of life (HRQOL) and healthcare costs in a European population with atrial fibrillation (AF). Methods and results: In the EURObservational Research Programme on AF long-term general registry, AF patients from 250 centres in 27 European countries were enrolled and followed for 2 years. We used fixed effects models to estimate the association of symptoms and CVD events on HRQOL and annual healthcare costs. We found significant decrements in HRQOL in AF patients in whom ST-segment elevation myocardial infarction (STEMI) [−0.075 (95% confidence interval −0.144, −0.006)], angina or non-ST-elevation myocardial infarction (NSTEMI) [−0.037 (−0.071, −0.003)], new-onset/worsening heart failure [−0.064 (−0.088, −0.039)], bleeding events [−0.031 (−0.059, −0.003)], thromboembolic events [−0.071 (−0.115, −0.027)], mild symptoms [0.037 (−0.048, −0.026)], or severe/disabling symptoms [−0.090 (−0.108, −0.072)] occurred during the follow-up. During follow-up, annual healthcare costs were associated with an increase of €11 718 (€8497, €14 939) in patients with STEMI, €5823 (€4757, €6889) in patients with angina/NSTEMI, €3689 (€3219, €4158) in patients with new-onset or worsening heart failure, €3792 (€3315, €4270) in patients with bleeding events, and €3182 (€2483, €3881) in patients with thromboembolic events, compared with AF patients without these events. Healthcare costs were primarily driven by inpatient costs. There were no significant differences in HRQOL or healthcare resource use between EU regions or by sex. Conclusion: Symptoms and CVD events are associated with a high burden on AF patients and healthcare systems throughout Europe. |
| spellingShingle | Walli-Attaei, M Little, M Luengo-Fernandez, R Gray, A Torbica, A Maggioni, AP Bairami, F Huculeci, R Aboyans, V Timmis, AD Vardas, P Leal, J Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title | Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title_full | Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title_fullStr | Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title_full_unstemmed | Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title_short | Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry |
| title_sort | health related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation a longitudinal analysis of 27 countries from the eurobservational research programme on atrial fibrillation general long term registry |
| work_keys_str_mv | AT walliattaeim healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT littlem healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT luengofernandezr healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT graya healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT torbicaa healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT maggioniap healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT bairamif healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT huculecir healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT aboyansv healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT timmisad healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT vardasp healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry AT lealj healthrelatedqualityoflifeandhealthcarecostsofsymptomsandcardiovasculardiseaseeventsinpatientswithatrialfibrillationalongitudinalanalysisof27countriesfromtheeurobservationalresearchprogrammeonatrialfibrillationgenerallongtermregistry |